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Background: Approximately 90 haemoglobinopathies have been identified that result in abnormally high oxygen
affinity. One of these is haemoglobinopathy York (HbY), first described in 1976. HbY causes an extreme leftward
shift of the oxygen dissociation curve with the P50 value changing to 12.5 - 15.5 mmHg (normal value 26.7 mmHg),
indicating that approximately half of the haemoglobin is not available as oxygen carrier. Patients with
haemoglobinopathies with increased oxygen affinity could suffer from the risk developing ischaemic complications
due to a lack of functional oxygen carriers. This is, to best of our knowledge, the first case report on a patient with
HbY published in connection with anesthesia.
Case Presentation: A 42-year-old female with a severe headache and Glasgow coma scale (GCS) of 15 was
admitted to the neurosurgical intensive care unit with a ruptured, right sided ICA aneurysm with consecutive
subarachnoid haemorrhage [Fisher III, World Federation of Neurosurgical Societies (WFNS) I)]. The medical history of
the patient included an erythrocytosis (Hb 17.5 g/dl) on the base of a high-oxygen-affinity haemoglobinopathy,
called Hb York (HbY). With no time available to take special preoperative precautions, rapid blood loss occurred
during the first attempt to clip the aneurysm. General transfusion procedures, according to the guidelines based on
haemoglobin and haematocrit values, could not be applied due to the uncertainty in the oxygen carrier reduction.
To maintain tissue oxygen supply, clinical indicators of ischaemia were instead utilized to gauge the appropriate
required blood products, crystalloids and colloids replacements. Despite this, the patient survived the neurosurgical
intervention without any neurological deficit.
Conclusions: Family members of patients with HbY (and other haemoglobinopathies with increased oxygen
affinity) should undergo clinical assessment, particularly if they are polycythaemic. If the diagnosis of HbY is
confirmed, they should carry an "emergency anaesthesiology card" in order to avert perioperative risks arising from
their "hidden" anemia.
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HypoxiaBackground
Haemoglobinopathy is defined as a genetic defect that
results in an abnormal structure of one of the globin
chains of the haemoglobin molecule. It is the most fre-
quently occurring monogenic disorder [1]. To date,
more than 1000 varieties have been described. Although
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reproduction in any medium, provided the orfindings like erythrocytosis and/or haemolysis, only a
few cause severe clinical symptoms. Well-known exam-
ples of haemoglobinopathies with severe clinical pheno-
type are sickle cell disease, beta-thalassemia or Hb S/C
disease.
Approximately 90 haemoglobinopathies have been
identified that result in abnormally high oxygen affin-
ities. The first was reported in 1966 on an 81-year-old
patient who presented with polycythemia [2]. Decreased
oxygen supply causes erythrocytosis, with clinical fea-
tures depending on the degree of abnormal oxygenl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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haemoglobinopathy York (HbY), first described in 1976
[3]. A second and third case was reported in 1983 and
2001, respectively [4,5]. Patients with haemoglobinopa-
thies with increased oxygen affinity could suffer from an
additional increased risk developing ischaemic complica-
tions when undergoing surgery with a higher risk of
blood loss or circulatory arrest due to a lack of func-
tional oxygen carriers. In 1997, an 11-year-old patient
with Hb Bryn Mawr was reported who was intensively
prepared for a cholecystectomy by performing partial ex-
change transfusion to prevent tissue hypoxia during an-
aesthesia. Hb Bryn Mawr is an unstable Hb variant
resulting in congenital haemolytic anaemia and
increased oxygen affinity [6]. We wish to report the case
of a patient with HbY who survived a life-threatening
situation characterized by subarachnoid haemorrhage
and severe perioperative aneurysmal bleeding. To the
best of our knowledge, this is only the fourth published
case of HbY worldwide and the first case published in
connection with anaesthesia.
Case presentation
A 42-year-old female with a severe headache and Glas-
gow Coma Scale (GCS) of 15 was admitted from a re-
gional hospital close to our neurosurgical intensive care
unit. Digital subtraction angiography showed a ruptured,
right-sided ICA aneurysm near the bifurcation followed
by a subarachnoid haemorrhage (Fisher III, World Fed-
eration of Neurosurgical Societies I: GCS 15, no motoric
deficit). A neurological examination revealed no deficits.
The medical history of the patient included obesity (a
body mass index of 29), Hashimoto thyroiditis, and an
erythrocytosis (Hb 17.5 g/dl), in addition to the HbY.
The diagnosis of HbY was initially performed at the Uni-
versity of Ulm (Germany) in 2002 through molecular
genetic analysis, subsequent to the exclusion of alterna-
tive explanations for erythrocytosis. Preoperative labora-
tory findings showed a haematocrit of 54%, Hb 17.5 g/dl,
reticulocytes 25/1000 and erythrocytes 6.2 x 106/μl.
After induction of anaesthesia with propofol (2 mg/
kg), remifentanyl (0.5 μg/kg/min) and rocuronium
(70 mg), an arterial and a central-venous catheter were
placed in addition to two peripheral intravenous 17 G
catheters. The lungs were ventilated with a fraction of
inspired oxygen (FiO2) of 0.5 and a minute ventilation
(MV) of 110 ml/min/kg. Nimodipine was continually
administered at a rate of 1 mg/h. Anaesthesia was main-
tained with Propofol (8 mg/kg/h) and Remifentanyl
(0.25 μg/kg/h). The operation was started and pro-
gressed uneventfully until the surgeon tried to dissect
the basis of the aneurysm, which led to severe bleeding.
Several temporary clips were required to stop the haem-
orrhage (approx. 1600 ml). Subsequent to volumeresuscitation with 1000 ml Ringer's solution and 500 ml
of volume expander (hydroxyethyl starch; HAES) 130/
0.4, the haemoglobin value was 10.8 g/dl. During the
bleeding interval, no S-T segment changes were
observed. However, typical signs of rapid fluid loss, such
as a moderately increased heart rate and a temporary
drop in blood pressure, were present. Systolic blood
pressure was always kept between 120 mmHg and
140 mmHg using noradrenalin in varying dosages (max.
0.25 μg/kg/min). Meanwhile, the patient received 6 units
of packed red blood cells (PRBC) and further fluid
substitutions.
Further bleeding was stopped by continuous compres-
sion with TachoSilW, enabling the obliteration of the
aneurysm. No vascular occlusions were detected on an
indocyanine green angiography. The blood pressure was
subsequently pharmacologically raised to a systolic value
of approximately 140 mmHg, with no further detectable
haemorrhaging. It was possible to extubate the patient
within a few minutes upon completion of the operation.
Immediate neurological assessment revealed no detect-
able deficits. The patient was transferred to the intensive
care unit with haemoglobin of 16.8 g/dl. Further recov-
ery was uneventful.
Conclusions
This case report describes a high urgency neurosurgical
intervention in a patient with HbY. There was no time
for taking special preoperative precautions, as described
by Larson et al. [6], as our patient experienced sudden
and rapid blood loss. The first Hb value was 10.8 g/dl.
The guidelines of the German Medical Association rec-
ommend that attempts should be made to maintain
intraoperative Hb concentrations above 10 g/dl in case
of acute bleeding. Taking into account the fact that ap-
proximately half of the patient's haemoglobin was non-
functional, a more accurate estimate of the "functional"
or "actual" Hb level would have been about 5.4 g/dl. For-
tunately, the reaction to the sudden blood loss was not
dramatic. There was neither clinical nor laboratory evi-
dence of ischemia. Our patient was generously trans-
fused, achieving a haemoglobin concentration of 16.8 g/
dl by the end of surgery. However, it appears rather diffi-
cult to assess how much haemoglobin was functional
when a blood loss of 1600 ml (containing approximately
800 ml HbY) was substituted with 1200 ml "healthy"
PRBC with a haematocrit of 60%. When performing
such a rough or ‘ballpark’ estimate, the use of the follow-
ing calculation is proposed: Starting with a Hb of 17.5 g/
dl, a blood loss of approximately 40% to 10.8 g/dl was
nearly compensated with PRBC to Hb 16.8 g/dl. The lost
blood contained HbY and "healthy" blood in an equal
ratio, thus 20% of lost blood was "pure" HbY. This was
substituted with 100% healthy blood, leading to a shift in
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50%+20%) and an estimated value of a functional haemo-
globin concentration of 11.8 g/dl (70% of 16.8 g/dl). How-
ever, a storage-related depletion of 2.3-diphosphoglycerate
(2.3-DPG) content in erythrocytes causing an additional
leftward shift of the oxygen-dissociation curve could de-
crease oxygen transport capacity.
During anaesthesia, we discover no deviation in pulse
oxymetry readings in comparison to arterial blood gas
analysis. This fact stands in apparent contrast to a theor-
etical overestimation of pulse oxymetric values, as half
of the haemoglobin is already- and remains irreversible
saturated with oxygen. For example, overestimated
values measured with commonly used two-wave pulse
oxymeters are found in patients with carbon monoxide in-
toxication due to the similar absorption spectrum of irre-
versible saturated haemoglobin and oxygenated
haemoglobin. In addition overestimated oxymetry read-
ings have also been found in, for example, high oxygen af-
finity haemoglobin Koln, which is associated with a left-
shifted oxygen dissociation curve [7]. Taking into account
the limitations of conventional oximetry, especially in
these patient populations, an alternative monitoring
method should be employed, such as arterial blood gas
analysis or end-tidal oxygen concentration monitoring
[8,9]. Furthermore, new presence of arrhythmia or
changes of S-T segment, an increase of oxygen extraction
rate greater than 50% and a decrease of oxygen consump-
tion of more than 10% could serve as commonly accepted
assessment of an adequate oxygen delivery.
The overall goal was to maintain blood pressure at a
preoperative level until the aneurysm was taken care of.
This was achieved by adjusting accordingly the levels of
noradrenalin administration. During the acute bleeding,
the preferred technique for gaining control over the rup-
tured aneurysm was to temporarily occlude the vessel
instead of a transiently decreasing the mean arterial
pressure. As part of the triple-H therapeutic strategy,
haemodilution could not be performed as the team iden-
tified hypoxia as the most dangerous threat to the pa-
tient and tried to stabilize the "actual" Hb at a
reasonably high level. The choice of anaesthetic drugs
led to a rapid and smooth emergence from anaesthesia,
which allowed an early neurological assessment.
The patient's history of haemoglobinopathy begun when
a general practitioner suspected polycythaemia vera as an
underlying cause for a chronic erythrocytosis. Common
causes, including cigarette smoking, psychosocial stress,
chronic residence at high altitudes and chronic lung dis-
ease, were excluded. Finally, HbY (α2 β2
146Pro) was identi-
fied by DNA sequencing, which indicated an autosomal
dominant inherited point mutation of codon 146, where
adenosine was exchanged for cytosine (CAC⇒CCC). The
mutation causes a change from histidine to proline atposition 146 in the β-globin chain. The mutant globin has
approximately twice the normal affinity for oxygen [3],
causing an extreme leftward shift of the oxygen dissoci-
ation curve, with the P50 changing from 26.5± 1.0 mmHg
to approximately 12.5 - 15.5 mmHg [4,5,10]. To date, only
heterozygotes carriers have been detected, suggesting that
this mutation is lethal for homozygotes. In heterozygote
individuals the red blood cells contain a 1:1 mixture of
HbY and normal HbA. The mutant HbY always remains
saturated with O2 and thus cannot serve the physiological
function of oxygen delivery. As a consequence of
decreased tissue oxygen supply, erythropoietin production
in the kidneys is upregulated, resulting in erythrocytosis.
Preoperative laboratory findings confirmed an usual com-
pensatory mechanism for chronic but moderate tissue
hypoxia.
Young individuals with Hb York are usually asymp-
tomatic. However, they are permanently at risk to suffer
from a state of "functional anaemia". Therefore, the fol-
lowing general advice may be justified: insufficient tissue
perfusion should be avoided by generous fluid intake, es-
pecially during hot weather or when pyrexia or diarrhoea
occurs; all pulmonary infections should be treated with-
out delay; and patients should not smoke and should
avoid travelling to high-altitude locations. Until more
knowledge has accumulated, it is difficult to comment
on the prognosis of individuals with HbY. As yet, these
individuals seem to have a normal life expectancy.
Nevertheless, they may become symptomatic when their
ability to compensate for their 50% dysfunctional
haemoglobin is compromised by congestive heart failure,
coronary heart disease, cerebrovascular insufficiency,
peripheral arterial disease, chronic or acute lung disease,
or pregnancy. In addition, carbon monoxide intoxication
or intoxications causing methaemoglobinemia or sulf-
haemoglobinemia may lead to critical situations due to a
critical level of dysfunctional haemoglobin. The same
may be true for rapid blood loss.
Chronic compensatory changes in patients suffering
from quantitative and qualitative anaemic diseases, in-
clude an up regulated cardiac output, a decreased vascu-
lar resistance, increased amount of erythrocyte and a
higher content of 2.3-DPG, which causes a right-shift
and thus a minimal compensation of the extremely left
shifted oxygen dissociation curve. Erythrocytosis causing
increased blood viscosity can lead to thromboembolic
complications, especially in elderly individuals with
haemoglobinopathy [11]. Recent investigations suggest
that preoperative anaemia increases the risk of post-
operative mortality [12]. In our patient, the preoperative
situation was characterized by a "functional" anaemia, a
lack of an appropriate level of oxygen carriers, despite a
Hb concentration of 17.5 g/dl. Severe intraoperative
haemorrhaging aggravated the situation. Fortunately, the
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immediate volume substitution, catecholamine adminis-
tration and a generous blood transfusion. We feel that
our experience does not allow us to draw any conclu-
sions as to the benefit of partial exchange transfusions as
a preoperative preparatory regimen. Additionally, the
special precautions carried out by Larson et al. in 1997
in a patient with Hb Bryn Mawr seemed to be an exces-
sive precaution [6]. From our point of view, a young per-
son who lived his entire life in complete stability and
most probably in adequate oxygen delivery environment
does not need an exchange transfusion for a minor
procedure.
Family members of patients with HbY (and other hae-
moglobinopathies with increased oxygen affinity) should
undergo clinical assessment, particularly if they are poly-
cythaemic. If the diagnosis of HbY is confirmed, they
should carry an "emergency anaesthesiology card" in
order to avert perioperative risks arising from their "hid-
den" anaemia. It should be emphasized that general
transfusion guidelines are not applicable to individuals
with this rare condition. Therapeutic attempts at de-
creasing the abnormal oxygen affinity using bezafibrates
are still being investigated. Venesection seems to only be
sensible in case of repetitive thrombotic events, but the
risk of an ischaemia is always present in these patients.Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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